To prove this hypothesis, we first used ChIP assay to detect the binding of EZH2 and PDCD4 promoter region in ESCC cells without any treatment (Additional file 2: Fig. S8). This evidence concerns the gene PDCD4 and esophageal squamous cell carcinoma.